SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| SIGMA HEALTHCARE LIMITED | 08/05/2017 | |
| SIGMA PHARMACEUTICALS LIMITED | 04/05/2017 | 08/05/2017 |
| SIGMA PHARMACEUTICALS LIMITED | 13/12/2005 | 04/05/2017 |
| ARROW PHARMACEUTICALS LIMITED | 13/12/2005 |
Liberty Place Level 41 161 Castlereagh St Sydney NSW 2000 Locked Bag A14 Sydney South NSW 1235
Tel : 1300 554 474many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service | 31/03/2022 |
company ticker changed to SIG | 04/05/2017 |
The former managing director and CEO of Sigma Pharmaceuticals Ltd "“ Elmo De Alwis, and former chief financial officer "“ Mark Smith, were today sentenced in the Melbourne County Court for charges relating to falsifying Sigma's books and giving false or misleading information to Sigma's directors and auditors | 26/05/2016 |
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Aspen Pharmacare Holdings Limited proposes to acquire all the issued shares - this corporate event may appear elsewhere in this company record | 03/04/2012 |
the suspension of trading in the securities of Sigma Pharmaceuticals Limited will be lifted immediately, following lodgement of their Full Year Results for the period ended 31 January 2010 | 31/03/2010 |
the securities of Sigma Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company | 01/03/2010 |
name changed from Arrow Pharmaceuticals Limited | 13/12/2005 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 30/01/2017 | Mark Hooper | -600,000 | $1.211 | $726,708.00 |
| 23/01/2017 | Mark Hooper | -885,796 | $1.242 | $1,099,999.00 |
| 25/10/2016 | Mark Hooper | -272,608 | $1.402 | $382,152.00 |
| 17/05/2016 | Mark Hooper | -2,984,115 | $1.160 | $3,470,883.00 |
| 19/04/2016 | Kate Spargo | 50,000 | $1.085 | $54,250.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Brian Jamieson | Non Exec Chairman | 05/12/2005 |
| Mark Hooper | Managing Director, CEO | 30/08/2010 |
| Iona MacPherson | CFO | 02/11/2016 |
| Kate Spargo | Independent Director | 09/12/2015 |
| Christine Bartlett | Independent Director | 30/03/2016 |
| David Bayes | Non Exec Director | 25/06/2007 |
| David Manuel | Non Exec Director | 26/10/2009 |
| Ray Gunston | Non Exec Director | 01/10/2009 |
| Susan Morgan | General Counsel | 01/01/2008 |
| Jeff Sells | General Manager | 01/08/2010 |
| Gary Woodford | Investor Relations | |
| Sam Lawson | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
